Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

3.22 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -62.255-94.66-94.66-122.725-91.14-60.08-26.554-13.209
Depreciation & Amortization 13.1612.66812.6681.8791.4670.320.1770.116
Deferred Income Tax -1.249-1.424-1.4241.1150.536-0.41400
Stock Based Compensation 10.71612.1611.3818.2736.4841.7280.4990.54
Change In Working Capital -6.294-35.15-35.1511.854-2.7981.6071.121-3.583
Accounts Receivables -8.367-13.374-13.374-6.237-2.182-1.67-1.0980.204
Inventory -14.804-7.465-7.465-7.418-5.1434.0421.698-0.846
Accounts Payables 6.959-4.318-4.3185.527-2.486-1.110.661-2.909
Other Working Capital 9.918-9.993-9.99319.9827.0130.345-0.14-0.032
Other Non Cash Items -2.2863.5153.5150.9613.1040.560.0940.049
Operating Cash Flow -48.208-102.891-102.891-95.535-80.558-56.279-24.663-16.087
Investing Activities:
Investments In Property Plant And Equipment -2.263-0.524-0.524-1.085-0.377-1.51-0.7-0.035
Acquisitions Net 0038.46938.4690.377000
Purchases Of Investments -43.7410-43.02-43.02-101.773-68.85100
Sales Maturities Of Investments 4034.98534.985103.674.7452.100
Other Investing Activites -3.74134.9854.551-27.028-0.377-66.75100
Investing Cash Flow -6.00434.46134.46197.964-27.405-68.261-0.7-0.035
Financing Activities:
Debt Repayment 0-43.496-43.496-25.089-25.089-34.6670-0.032
Common Stock Issued 0.58130302765.89198.3250.1590.071
Common Stock Repurchased -1.009-0.468-0.468-0.534-0.063000
Dividends Paid 00000000
Other Financing Activities -0288.487141.43750.959180.96829.88635.1393.936
Financing Cash Flow -0.428127.473127.47327.247126.064128.21135.1393.904
Other Information:
Effect Of Forex Changes On Cash 0.1230-0.003-0.003-0.022000
Net Change In Cash -54.51759.04359.04329.67318.0793.6719.776-12.218
Cash At End Of Period 67.449126.314126.31467.27137.59845.71642.04532.269